C. Box

发表

Photoacoustic imaging for the prediction and assessment of response to radiotherapy in vivo

J. Bamber, G. Haar, Márcia Martinho Costa, 2018, bioRxiv.

The challenge of targeting cancer stem cells to halt metastasis.

C. Box, A. Calvo, A. Agliano, 2017, Seminars in cancer biology.

Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck.

K. Harrington, S. Eccles, C. Box, 2007, Cancer research.

Pre-clinical quantitative imaging and mouse-specific dosimetry for 111In-labelled radiotracers

T. Spinks, S. Eccles, C. Box, 2016, EJNMMI Research.

Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer

K. Syrigos, K. Harrington, R. A’Hern, 2006, British Journal of Cancer.

3D tumour spheroids for the prediction of the effects of radiation and hyperthermia treatments

U. Oelfke, I. Rivens, C. Box, 2020, Scientific Reports.

Intratumoural hydrogen peroxide with radiotherapy in locally advanced breast cancer: results from a Phase I clinical trial.

E. Sawyer, D. Tait, J. Yarnold, 2020, International journal of radiation oncology, biology, physics.

A novel serum protein signature associated with resistance to epidermal growth factor receptor tyrosine kinase inhibitors in head and neck squamous cell carcinoma.

B. Al-Lazikani, K. Harrington, M. Valenti, 2013, European journal of cancer.

Angiogenic Functions of Voltage-gated Na+ Channels in Human Endothelial Cells

S. Eccles, D. Ottaviani, C. Box, 2011, The Journal of Biological Chemistry.

MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck.

K. Harrington, S. Eccles, C. Box, 2011, European journal of cancer.

Non-invasive molecular profiling of cancer using photoacoustic imaging of functionalized gold nanorods

Erwin J. Alles, Jeffrey C. Bamber, Suzanne A. Eccles, 2014, Photonics West - Biomedical Optics.

Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI

S. Bhide, K. Harrington, D. Koh, 2017, Clinical Cancer Research.

HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells

S. Eccles, C. Box, Suyanee Thongchot, 2022, BMC cancer.

Cell migration/invasion assays and their application in cancer drug discovery.

S. Eccles, C. Box, W. Court, 2005, Biotechnology annual review.

Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours

M. Leach, H. Parkes, M. Valenti, 2015, British Journal of Cancer.

Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling

S. Eccles, S. Eccles, M. van Schalkwyk, 2012, Journal of Clinical Immunology.

Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling

S. Eccles, J. Maher, C. Box, 2012, Journal of Clinical Immunology.

Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neck

K. Harrington, P. Workman, C. Nutting, 2009, The Journal of pathology.

Three-Dimensional (3D) Tumor Spheroid Invasion Assay

Suzanne A. Eccles, Maria Vinci, Carol Box, 2015, Journal of visualized experiments : JoVE.

Tumour-microenvironmental interactions: paths to progression and targets for treatment.

S. Eccles, M. Mendiola, C. Box, 2010, Seminars in cancer biology.

The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck

K. Harrington, C. Nutting, S. Eccles, 2005, Expert opinion on therapeutic targets.

The effect of FASN inhibition on the growth and metabolism of a cisplatin‐resistant ovarian carcinoma model

N. deSouza, C. Box, Yuen-Li Chung, 2018, International journal of cancer.

Tumor spheroid-based migration assays for evaluation of therapeutic agents.

S. Eccles, C. Box, Miriam Zimmermann, 2013, Methods in molecular biology.

Molecular markers of response and resistance to EGFR inhibitors in head and neck cancers.

S. Eccles, C. Box, Miriam Zimmermann, 2013, Frontiers in bioscience.

EGFR signaling in invasion, angiogenesis and metastasis

S. Eccles, C. Box, S. Rogers, 2008 .

Flexible Targeting of ErbB Dimers That Drive Tumorigenesis by Using Genetically Engineered T Cells

S. Eccles, M. van Schalkwyk, S. Mather, 2012, Molecular medicine.

Quantification of Differential Response of Tumour and Normal Cells to Microbeam Radiation in the Absence of FLASH Effects

U. Oelfke, C. Box, S. Bartzsch, 2021, Cancers.

International Society for Therapeutic Ultrasound Conference 2016

Megan E Poorman, Eric L. Miller, Jonathan T. Sutton, 2017, Journal of Therapeutic Ultrasound.

3D tumour spheroids for the prediction of the effects of radiation and hyperthermia treatments

U. Oelfke, I. Rivens, C. Box, 2020, Scientific Reports.

Evaluating Imaging Biomarkers of Acquired Resistance to Targeted EGFR Therapy in Xenograft Models of Human Head and Neck Squamous Cell Carcinoma

T. Spinks, M. Leach, S. Robinson, 2018, Front. Oncol..

Two-dimensional vs. three-dimensional in vitro tumor migration and invasion assays.

S. Eccles, C. Box, Miriam Zimmermann, 2013, Methods in molecular biology.

Brk/PTK6 and Involucrin Expression May Predict Breast Cancer Cell Responses to Vitamin D3

S. Eccles, S. Hare, A. Harvey, 2023, International Journal of Molecular Sciences.

Quantitative photoacoustic imaging study of tumours in vivo: Baseline variations in quantitative measurements

Jeffrey Bamber, Ian Rivens, Gail ter Haar, 2018, bioRxiv.

The challenge of targeting cancer stem cells to halt metastasis.

C. Box, A. Calvo, A. Agliano, 2017, Seminars in cancer biology.

Tumour-microenvironmental interactions: paths to progression and targets for treatment.

S. Eccles, M. Mendiola, C. Box, 2010, Seminars in cancer biology.

Abstract 4459: Evaluating imaging biomarkers of acquired resistance to targeted EGFR therapy in xenograft models of human squamous cell carcinoma of the head and neck (SCCHN).

S. Robinson, G. Box, S. Eccles, 2013 .